The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 01, 2016

Filed:

May. 19, 2009
Applicants:

Erning Xia, Penfield, NY (US);

Michael E. Allen, Webster, NY (US);

Steven K. Macleod, Henrietta, NY (US);

Tammy J. Kleiber, Rochester, NY (US);

Craig M. Cody, Scottsville, NY (US);

Inventors:

Erning Xia, Penfield, NY (US);

Michael E. Allen, Webster, NY (US);

Steven K. MacLeod, Henrietta, NY (US);

Tammy J. Kleiber, Rochester, NY (US);

Craig M. Cody, Scottsville, NY (US);

Assignee:

Bausch & Lomb Incorporated, Rochester, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 33/40 (2006.01); C11D 3/00 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 31/715 (2006.01); A61K 31/726 (2006.01); A61K 31/728 (2006.01); A61K 31/734 (2006.01); A61K 47/08 (2006.01); A61K 47/10 (2006.01); A61K 47/36 (2006.01); A61L 12/12 (2006.01); A61L 12/14 (2006.01); C11D 3/22 (2006.01); C11D 3/39 (2006.01);
U.S. Cl.
CPC ...
C11D 3/0078 (2013.01); A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 31/715 (2013.01); A61K 31/726 (2013.01); A61K 31/728 (2013.01); A61K 31/734 (2013.01); A61K 33/40 (2013.01); A61K 47/08 (2013.01); A61K 47/10 (2013.01); A61K 47/36 (2013.01); A61L 12/124 (2013.01); A61L 12/14 (2013.01); A61L 12/145 (2013.01); C11D 3/222 (2013.01); C11D 3/3947 (2013.01);
Abstract

A pharmaceutical formulation that is effective in adversely affecting the viability of microorganisms or in inhibiting their growth and that provides better safety and/or comfort to the users comprises a polysaccharide, a source of hydrogen peroxide, and an anti-oxidant. The formulation can further comprise a chelating agent and/or an ophthalmically active agent for treating or controlling a disease or disorder of the eye. The formulation may be used to treat, clean, disinfect, store, wet, or rewet contact lenses.


Find Patent Forward Citations

Loading…